China’s Good Clinical Practice (GCP) guidelines emphasize ethical treatment of participants, scientific validity, clear documentation, and data accuracy. Ensuring patient safety, informed consent, and regular monitoring are paramount. China’s GCP aligns with international standards, ensuring clinical trials are conducted with utmost integrity and transparency within its jurisdiction.
